Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar muffmutt (54.64) Submitted: 11/30/2010 3:33:55 AM : Outperform Start Price: $3.91 ARIA Score: +314.58

echnicals

Report this Post Reply

Featured Broker Partners


Advertisement